Ping An Healthcare and Technology Company Limited
Ping An Healthcare and Technology Company Limited Fundamental Analysis
Ping An Healthcare and Technology Company Limited (PANHF) shows weak financial fundamentals with a PE ratio of 133.28, profit margin of 3.05%, and ROE of 2.39%. The company generates $5.7B in annual revenue with weak year-over-year growth of 2.88%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 37.7/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze PANHF's fundamental strength across five key dimensions:
Efficiency Score
WeakPANHF struggles to generate sufficient returns from assets.
Valuation Score
ModeratePANHF shows balanced valuation metrics.
Growth Score
WeakPANHF faces weak or negative growth trends.
Financial Health Score
ExcellentPANHF maintains a strong and stable balance sheet.
Profitability Score
ModeratePANHF maintains healthy but balanced margins.
Key Financial Metrics
Is PANHF Expensive or Cheap?
P/E Ratio
PANHF trades at 133.28 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, PANHF's PEG of 0.79 indicates potential undervaluation.
Price to Book
The market values Ping An Healthcare and Technology Company Limited at 2.18 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 77.64 times EBITDA. This signals the market has high growth expectations.
How Well Does PANHF Make Money?
Net Profit Margin
For every $100 in sales, Ping An Healthcare and Technology Company Limited keeps $3.05 as profit after all expenses.
Operating Margin
Core operations generate 0.75 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $2.39 in profit for every $100 of shareholder equity.
ROA
Ping An Healthcare and Technology Company Limited generates $1.23 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Ping An Healthcare and Technology Company Limited generates limited operating cash flow of $323.86M, signaling weaker underlying cash strength.
Free Cash Flow
Ping An Healthcare and Technology Company Limited produces free cash flow of $294.19M, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $0.14 in free cash annually.
FCF Yield
PANHF converts 1.18% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
133.28
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.79
vs 25 benchmark
P/B Ratio
Price to book value ratio
2.18
vs 25 benchmark
P/S Ratio
Price to sales ratio
4.41
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.005
vs 25 benchmark
Current Ratio
Current assets to current liabilities
3.15
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.02
vs 25 benchmark
ROA
Return on assets percentage
0.01
vs 25 benchmark
ROCE
Return on capital employed
0.004
vs 25 benchmark
How PANHF Stacks Against Its Sector Peers
| Metric | PANHF Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 133.28 | 28.25 | Worse (Expensive) |
| ROE | 2.39% | 780.00% | Weak |
| Net Margin | 3.05% | -20122.00% (disorted) | Weak |
| Debt/Equity | 0.00 | 0.30 | Strong (Low Leverage) |
| Current Ratio | 3.15 | 4.66 | Strong Liquidity |
| ROA | 1.23% | -14687.00% (disorted) | Weak |
PANHF outperforms its industry in 2 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Ping An Healthcare and Technology Company Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
-16.14%
Industry Style: Defensive, Growth, Innovation
DecliningEPS CAGR
109.80%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
117.41%
Industry Style: Defensive, Growth, Innovation
High Growth